EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Folate-Modified Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and In Vitro PDT Treatment of Breast Cancer Cell Lines

Anna V Bychkova iD, Maria G Gorobets, Anna V Toroptseva, Alina A Markova iD, Minh Tuan Nguyen iD, Yulia L Volodina, Margarita A Gradova iD, Madina I Abdullina, Oksana A Mayorova iD, Valery V Kasparov iD, Vadim S Pokrovsky iD, Anton V Kolotaev iD und 1 weitere

Pharmaceutics · 30.07.2025 · 17 (8) · 982

DOI: 10.3390/pharmaceutics17080982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 30.07.2025. Verfasst von Anna V Bychkova und 12 weiteren Autor:innen. Beteiligte Einrichtung: Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 4, Kosygina Str., Moscow 119334, Russia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education, Russian Federation, Russian Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Magnetic iron oxide nanoparticles (IONPs), human serum albumin (HSA) and folic acid (FA) are prospective components for hybrid nanosystems for various biomedical applications. The magnetic nanosystems FA-HSA@IONPs (FAMs) containing IONPs, HSA, and FA residue are engineered in the study.

Methods

Composition, stability and integrity of the coating, and peroxidase-like activity of FAMs are characterized using UV/Vis spectrophotometry (colorimetric test using o-phenylenediamine (OPD), Bradford protein assay, etc.), spectrofluorimetry, dynamic light scattering (DLS) and electron magnetic resonance (EMR). The selectivity of the FAMs accumulation in cancer cells is analyzed using flow cytometry and confocal laser scanning microscopy.

Results

FAMs (dN~55 nm by DLS) as a drug delivery platform have been administered to cancer cells (human breast adenocarcinoma MCF-7 and MDA-MB-231 cell lines) in vitro. Methylene blue, as a model photosensitizer, has been non-covalently bound to FAMs. An increase in photoinduced cytotoxicity has been found upon excitation of the photosensitizer bound to the coating of FAMs compared to the single photosensitizer at equivalent concentrations. The suitability of the nanosystems for photodynamic therapy has been confirmed.

Conclusions

FAMs are able to effectively enter cells with increased folate receptor expression and thus allow antitumor photosensitizers to be delivered to cells without any loss of their in vitro photodynamic efficiency. Therapeutic and diagnostic applications of FAMs in oncology are discussed.

Schlagwörter

Stichwörter der Autor:innen

folic acidhuman serum albumin (HSA)hybrid magnetic nanosystemsiron oxide nanoparticles (IONPs)methylene bluephotodynamic therapy (PDT)theranostics

Autor:innen und Institutionen

  • Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 4, Kosygina Str., Moscow 119334, Russia.
  • N.N. Blokhin National Medical Research Center of Oncology, 24, Kashirskoye Sh., Moscow 115478, Russia.
  • N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, 4, Kosygina Str., Moscow 119991, Russia.
  • Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., Saratov 410012, Russia.
  • Department of Biochemistry, Institute of Medicine, RUDN University, 6, Miklukho-Maklaya Str., Moscow 117198, Russia.

ORCID-Profile: Anna V Bychkova, Alina A Markova, Minh Tuan Nguyen, Margarita A Gradova, Oksana A Mayorova, Valery V Kasparov, Vadim S Pokrovsky, Anton V Kolotaev

Förderung

  • Russian Science Foundation
  • Ministry of Science and Higher Education, Russian Federation
  • Russian Academy of Sciences

Zitieren

APA

Bychkova, A. V., Gorobets, M. G., Toroptseva, A. V., Markova, A. A., Nguyen, M. T., Volodina, Y. L., Gradova, M. A., Abdullina, M. I., Mayorova, O. A., Kasparov, V. V., Pokrovsky, V. S., Kolotaev, A. V., & Khachatryan, D. S. (2025). Folate-Modified Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and In Vitro PDT Treatment of Breast Cancer Cell Lines. Pharmaceutics, 17(8), 982. https://doi.org/10.3390/pharmaceutics17080982

Vancouver

Bychkova AV, Gorobets MG, Toroptseva AV, Markova AA, Nguyen MT, Volodina YL, et al. Folate-Modified Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and In Vitro PDT Treatment of Breast Cancer Cell Lines. Pharmaceutics. 2025;17(8):982. doi:10.3390/pharmaceutics17080982

BibTeX
@article{Bychkova2025,
  author = {Bychkova, Anna V and Gorobets, Maria G and Toroptseva, Anna V and Markova, Alina A and Nguyen, Minh Tuan and Volodina, Yulia L and Gradova, Margarita A and Abdullina, Madina I and Mayorova, Oksana A and Kasparov, Valery V and Pokrovsky, Vadim S and Kolotaev, Anton V and Khachatryan, Derenik S},
  title = {Folate-Modified Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and In Vitro PDT Treatment of Breast Cancer Cell Lines},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {982},
  doi = {10.3390/pharmaceutics17080982}
}
Kostenlos starten →